Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pradusinstobart by Lyvgen Biopharma for Advanced Malignancy: Likelihood of Approval
Pradusinstobart is under clinical development by Lyvgen Biopharma and currently in Phase I for Advanced Malignancy. According to GlobalData, Phase...